N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension

Hemoglobin

Volumn 34, Issue 1, 2010, Pages 78-94

  Mokhtar, Galila M ^a   Adly, Amira A M ^a   Alfy, Mohsen S El ^a   Tawfik, Lamis M ^b   Khairy, Ahmed T ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

N terminal pro brain natriuretic peptide (NT pro BNP); Pulmonary hypertension (PH); Sickle cell disease; Thalassemia

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEMOLYSIS; HEMOSIDEROSIS; HUMAN; LUNG VENTILATION PERFUSION RATIO; MALE; PARAMETER; PREVALENCE; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; SCHOOL CHILD; SCREENING; SICKLE CELL ANEMIA; THALASSEMIA; TRICUSPID VALVE REGURGITATION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; VENTILATION-PERFUSION RATIO; YOUNG ADULT;

TOBACCO RATTLE VIRUS;

EID: 76449084357     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630260903554621     Document Type: Article

References (41)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187-1193.
2. Castro O, Gladwin MT. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19(5):881-896. (Pubitemid 41427115)
3. Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004; 350(9): 857-859.
4. Borgna-Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in b thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99(2):76-79.
5. Liem RI, Young LT, Thompson AA. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica. 2007;92(11):1549-1552.
6. Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med. 1994;35(5):793-796.
7. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680-684.
8. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105(5):595-601. (Erratum in: Circulation. 2002;106(3):387.)
9. Machado RF, Anthi A, Steinberg MH, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA. 2006;296(3):310-318.
10. Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, Eds. Thalassemia intermedia and Hb E. Guidelines for The Clinical Management of Thalassemia, 2nd ed. Nicosia: Thalassemia International Federation. 2008;11:121-131.
11. Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED study. Prospective investigation of pulmonary embolism diagnosis study. J Nucl Med. 1995;36(12):2380-2387.
12. Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressure in children with sickle cell disease. Pediatrics. 2008;121(4):777-782.
13. Vicari P, de Cassia Rosario Cavalheiro R, de Gouveia A, Filho Campos O, Figueiredo MS. Echocardiographic abnormalities in Brazilian sickle cell patients. Am J Hematol. 2005;78(2):160-161.
14. Manci EA, Culberson DE, Yang YM, et al. Investigators of the Cooperative Study of Sickle Cell Disease. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2):359-365.
15. Atichartakarn V, Likittanasombat K, Chuncharunee S, et al. Pulmonary arterial hypertension in previously splenectomized patients with b-thalassemic disorders. Int J Hematol. 2003;78(2):139-145.
16. Tam DH, Farber HW. Pulmonary hypertension and b-thalassemia major: report of a case, its treatment, and a review of the literature. Am J Hematol. 2006;81(6):443-447.
17. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532-537.
18. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysisassociated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-2285.
19. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81-90.
20. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662.
21. Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in b-thalassemia and the sickling syndrome. Blood. 2002;99(1):30-35.
22. Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities in inherited haemolytic syndromes. Eur J Clin Invest. 2002;32(9):640-642.
23. Kremastimes DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kallamis CA. Heart failure in b-thalassemia: a 5 year follow up study. Am J Med. 2001;111:349-434
24. Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E. Pulmonary hypertension in patients with sickle/b thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica. 2007;92(6):738-743.
25. Wu KH, Chang JS, Su BH, Peng CT. Tricuspid regurgitation in patients with b-thalassemia major. Ann Hematol. 2004;83(12):779-783.
26. Aessopos A, Farmakis D. Pulmonary hypertension in b-thalassemia. Ann NY Acad Sci. 2005;1054:342-349.
27. Ohga S, Ideguchi H, Kato J, et al. Thromboembolic complications in splenectomized patients with dominantly inherited b-thalassemia. Acta Haematol. 2008;120(1):31-35.
28. Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart. 2006;92(10):1467-1472.
29. Kato GJ, Hsieh M, Machado R, et al. Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol. 2006;81(7):503-510.
30. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294.
31. Onyekwere OC, Campbell A, Teshome M, et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008;29(2):309-312.
32. Souza R, Jardim C, Julio Cesar Femandes C, Sliveira Lapa M, Rabelo R, Humbert M. NT-pro-BNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med. 2007;101(1):69-75. (Pubitemid 44835241)
33. Bernus A, Wagner BD, Accurso F, Doran A, Kaess H, Ivy DD. Brain natriuritic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest. 2009,135(3):745-751.
34. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-895.
35. Fedullo PF, Auger WR, Kerr KM, Kim NH. Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med. 2003;24(3):273-286.
36. Lisbona R, Derbekyan V, Novales-Diaz J. Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease. J Nucl Med. 1997;38(7):1151-1153.
37. Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R. Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost. 2007;13(4):422-427.
38. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36-43.
39. Kaur N, Motwani B, Sivasubramaniam D, et al. Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease. Am J Hematol. 2004;77(4):407-409.
40. Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol. 1979;7(3):219-232.
41. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med. 2007;175(12):1272-1279.